BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1121 related articles for article (PubMed ID: 16884778)

  • 1. Prevalence of a normal C-reactive protein with an elevated erythrocyte sedimentation rate in biopsy-proven giant cell arteritis.
    Parikh M; Miller NR; Lee AG; Savino PJ; Vacarezza MN; Cornblath W; Eggenberger E; Antonio-Santos A; Golnik K; Kardon R; Wall M
    Ophthalmology; 2006 Oct; 113(10):1842-5. PubMed ID: 16884778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Giant cell arteritis and normal sedimentation rate: more than an exception!].
    von Blotzeim SG; Borruat FX
    Klin Monbl Augenheilkd; 1996 May; 208(5):397-9. PubMed ID: 8766063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of thrombocytosis in diagnosis of giant cell arteritis and differentiation of arteritic from non-arteritic anterior ischemic optic neuropathy.
    Costello F; Zimmerman MB; Podhajsky PA; Hayreh SS
    Eur J Ophthalmol; 2004; 14(3):245-57. PubMed ID: 15206651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of unilateral temporal artery biopsy.
    Hall JK; Volpe NJ; Galetta SL; Liu GT; Syed NA; Balcer LJ
    Ophthalmology; 2003 Mar; 110(3):543-8; discussion 548. PubMed ID: 12623818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of erythrocyte sedimentation rate and C-reactive protein for the diagnosis of giant cell arteritis.
    Kermani TA; Schmidt J; Crowson CS; Ytterberg SR; Hunder GG; Matteson EL; Warrington KJ
    Semin Arthritis Rheum; 2012 Jun; 41(6):866-71. PubMed ID: 22119103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of discordant temporal artery biopsy in the diagnosis of giant cell arteritis.
    Durling B; Toren A; Patel V; Gilberg S; Weis E; Jordan D
    Can J Ophthalmol; 2014 Apr; 49(2):157-61. PubMed ID: 24767221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Giant cell arteritis.
    Jain S; Shah A; Deane J
    Ophthalmology; 2007 Jun; 114(6):1235; author reply 1235-6. PubMed ID: 17544792
    [No Abstract]   [Full Text] [Related]  

  • 8. Giant cell arteritis: diagnosing and treating inflammatory disease in older adults.
    Azhar SS; Tang RA; Dorotheo EU
    Geriatrics; 2005 Aug; 60(8):26-30. PubMed ID: 16092890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biopsy-negative giant cell arteritis: clinical spectrum and predictive factors for positive temporal artery biopsy.
    Gonzalez-Gay MA; Garcia-Porrua C; Llorca J; Gonzalez-Louzao C; Rodriguez-Ledo P
    Semin Arthritis Rheum; 2001 Feb; 30(4):249-56. PubMed ID: 11182025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of histopathologic features, clinical symptoms, and erythrocyte sedimentation rates in biopsy-positive temporal arteritis.
    Diaz VA; DeBroff BM; Sinard J
    Ophthalmology; 2005 Jul; 112(7):1293-8. PubMed ID: 15921755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of giant cell arteritis: interleukin-6 as a biologic marker of disease activity.
    Weyand CM; Fulbright JW; Hunder GG; Evans JM; Goronzy JJ
    Arthritis Rheum; 2000 May; 43(5):1041-8. PubMed ID: 10817557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal artery biopsy is not required in all cases of suspected giant cell arteritis.
    Quinn EM; Kearney DE; Kelly J; Keohane C; Redmond HP
    Ann Vasc Surg; 2012 Jul; 26(5):649-54. PubMed ID: 22285348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agreement between erythrocyte sedimentation rate and C-reactive protein in hospital practice.
    Colombet I; Pouchot J; Kronz V; Hanras X; Capron L; Durieux P; Wyplosz B
    Am J Med; 2010 Sep; 123(9):863.e7-13. PubMed ID: 20800157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of the role of temporal artery biopsy in diagnosing clinically suspected giant cell arteritis.
    Varma D; O'Neill D
    Eye (Lond); 2004 Apr; 18(4):384-8. PubMed ID: 15069435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small-vessel vasculitis surrounding an uninflamed temporal artery: a new diagnostic criterion for polymyalgia rheumatica?
    Chatelain D; Duhaut P; Loire R; Bosshard S; Pellet H; Piette JC; Sevestre H; Ducroix JP
    Arthritis Rheum; 2008 Aug; 58(8):2565-73. PubMed ID: 18668584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythrocyte sedimentation rate and C-reactive protein in the evaluation of disease activity and severity in polymyalgia rheumatica: a prospective follow-up study.
    Cantini F; Salvarani C; Olivieri I; Macchioni L; Ranzi A; Niccoli L; Padula A; Boiardi L
    Semin Arthritis Rheum; 2000 Aug; 30(1):17-24. PubMed ID: 10966209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ischemic heart disease in patients from Northwest Spain with biopsy proven giant cell arteritis. A population based study.
    Gonzalez-Gay MA; Rubiera G; Piñeiro A; Garcia-Porrua C; Pego-Reigosa R; Gonzalez-Juanatey C; Sanchez-Andrade A; Llorca J
    J Rheumatol; 2005 Mar; 32(3):502-6. PubMed ID: 15742443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Giant cell temporal arteritis with a normal erythrocyte sedimentation rate: report of a case.
    Ciccarelli M; Jeanmonod D; Jeanmonod R
    Am J Emerg Med; 2009 Feb; 27(2):255.e1-3. PubMed ID: 19371556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Giant-cell arteritis with normal erythrocyte sedimentation rate: case report and review of the literature.
    Zweegman S; Makkink B; Stehouwer CD
    Neth J Med; 1993 Apr; 42(3-4):128-31. PubMed ID: 8316325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The erythrocyte sedimentation rate is associated with the development of visual complications in biopsy-proven giant cell arteritis.
    Lopez-Diaz MJ; Llorca J; Gonzalez-Juanatey C; Peña-Sagredo JL; Martin J; Gonzalez-Gay MA
    Semin Arthritis Rheum; 2008 Oct; 38(2):116-23. PubMed ID: 18221984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.